期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Vitreomacular Traction Post Intravitreal Bevacizumab for Age Related Macular Degeneration
1
作者 Okonkwo N. Ogugua Hassan O. Adekunle +5 位作者 Gyasi E. Micheal Oluyadi B. Fatai ogunro adunola Oderinlo Olufemi Ulaikere Mildred Harriman Ayodele 《Open Journal of Ophthalmology》 2017年第2期138-144,共7页
Purpose: To report the significant worsening of Vitreomacular Traction (VMT), following the intravitreal injection of Bevacizumab (Avastin) in an Age Related Macular Degeneration (AMD) eye;thereby raising the awarenes... Purpose: To report the significant worsening of Vitreomacular Traction (VMT), following the intravitreal injection of Bevacizumab (Avastin) in an Age Related Macular Degeneration (AMD) eye;thereby raising the awareness of this possibility. Method: Retrospective observational case report. Results: After 3 monthly doses of intravitreal injection of 1.25 mg/0.05 cc bevacizumab for treatment of AMD, a post injection OCT revealed the presence of VMT and an increased central macular thickness (CMT) by additional 268 microns compared to pre injection levels. Conclusion: Worsening of VMT and increase in CMT following injection of intravitreal drugs can occur. This VMT worsening effect of intravitreal injections is under recognized. It demands greater attention since it is seen with a new common route of ocular drug delivery and may be responsible for cases of pharmacological failure. 展开更多
关键词 Vitreomacular TRACTION Vitreomacular Adhesion INTRAVITREAL Injection Optical COHERENCE Tomography AVASTIN Age Related MACULAR DEGENERATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部